The amino terminus and the third extracellular loop of CX3CR1 contain determinants critical for distinct receptor functions.
The G protein-coupled receptor CX3CR1 is a specific receptor for the CX3C chemokine fractalkine (CX3CL1 according to the new chemokine nomenclature). The aim of this study was to identify receptor elements that contribute independently to agonist binding and receptor activation. Targeted mutation of selected acidic amino acid residues demonstrated that the binding activity of CX3CR1 was critically dependent on the two negatively charged residues Asp25 and Glu254 located on the N-terminal domain and third extracellular loop, respectively. In addition, mutation of the uncharged polar residue Tyr14 in the amino terminus caused a reduction in the ligand binding affinity. In contrast, the three acidic residues Glu13, Asp16, and Asp266 did not contribute to ligand binding but were crucial for receptor activation. The mutant receptors E13A, D16A, and D266A bound fractalkine with high affinity but were unable to induce signaling events necessary to support chemotaxis. These acidic residues may engage in electrostatic interactions with basic residues on fractalkine that are necessary for receptor function but not for binding. Our data are consistent with a model of chemokine receptor activation consisting of a multi-step mechanism. Step one mediates the high-affinity fractalkine binding involving Tyr14, Asp25, and Glu254. The initial interaction then triggers the engagement of Glu13, Asp16, and Asp266, which are necessary for CX3CR1 activation.
Chen
Yiming
Y
Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0682, USA.
Green
Simone R
SR
Almazan
Felicidad
F
Quehenberger
Oswald
O
D000595:Amino Acid Sequence; D001216:Asparagine / Q000737:chemistry / Q000235:genetics; D000073883:CX3C Chemokine Receptor 1; D002478:Cells, Cultured; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C / Q000378:metabolism*; D002633:Chemotaxis / Q000235:genetics / Q000502:physiology; D005973:Glutamine / Q000737:chemistry / Q000235:genetics; D006801:Humans; D008024:Ligands; D008565:Membrane Proteins / Q000819:agonists* / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D019950:Mitogen-Activated Protein Kinase 1 / Q000378:metabolism*; D048052:Mitogen-Activated Protein Kinase 3 / Q000378:metabolism*; D008969:Molecular Sequence Data; D009154:Mutation; D010766:Phosphorylation; D017434:Protein Structure, Tertiary; D019707:Receptors, Chemokine / Q000819:agonists* / Q000737:chemistry* / Q000235:genetics; D015398:Signal Transduction; D014443:Tyrosine / Q000737:chemistry / Q000235:genetics
D000073883:CX3C Chemokine Receptor 1; C515538:CX3CL1 protein, human; C095235:CX3CR1 protein, human; D054428:Chemokine CX3CL1; D020523:Chemokines, CX3C; D008024:Ligands; D008565:Membrane Proteins; D019707:Receptors, Chemokine; D005973:Glutamine; D014443:Tyrosine; D001216:Asparagine; D019950:Mitogen-Activated Protein Kinase 1; D048052:Mitogen-Activated Protein Kinase 3